Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity
暂无分享,去创建一个
[1] R. Johns,et al. Intact carrageenan-induced thermal hyperalgesia in mice lacking inducible nitric oxide synthase , 2003, Neuroscience.
[2] R. Huganir,et al. Impaired NMDA Receptor-Mediated Postsynaptic Function and Blunted NMDA Receptor-Dependent Persistent Pain in Mice Lacking Postsynaptic Density-93 Protein , 2003, The Journal of Neuroscience.
[3] Takao Shimizu,et al. Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor‐deficient mice and PAF receptor antagonist treatment , 2003, British journal of pharmacology.
[4] R. Koehler,et al. Potential Mechanism by Which Resveratrol, a Red Wine Constituent, Protects Neurons , 2003, Annals of the New York Academy of Sciences.
[5] S. Bennett,et al. Platelet activating factor‐induced apoptosis is inhibited by ectopic expression of the platelet activating factor G‐protein coupled receptor , 2002, Journal of neurochemistry.
[6] S. Estus,et al. Calpain activates caspase‐3 during UV‐induced neuronal death but only calpain is necessary for death , 2002, Journal of neurochemistry.
[7] M. Packard,et al. Differential Interaction of Platelet-Activating Factor and NMDA Receptor Function in Hippocampal and Dorsal Striatal Memory Processes , 2001, Neurobiology of Learning and Memory.
[8] S. Dewhurst,et al. Activation of glycogen synthase kinase 3 beta (GSK‐3β) by platelet activating factor mediates migration and cell death in cerebellar granule neurons , 2001, The European journal of neuroscience.
[9] Takao Shimizu,et al. Interaction between neurone and microglia mediated by platelet‐activating factor , 2000, Genes to cells : devoted to molecular & cellular mechanisms.
[10] R. Catalán,et al. Glutamate release is involved in PAF‐increased cyclic GMP levels in hippocampus , 1999, Biochemistry and molecular biology international.
[11] N. Bazan,et al. Recombinant plasma‐type platelet‐activating factor acetylhydrolase attenuates NMDA‐induced hippocampal neuronal apoptosis , 1998, Journal of neuroscience research.
[12] Y. Hirashima,et al. Involvement of platelet-activating factor (PAF) in glutamate neurotoxicity in rat neuronal cultures , 1997, Brain Research.
[13] N. Bazan,et al. Platelet-activating factor in the modulation of excitatory amino acid neurotransmitter release and of gene expression. , 1996, Journal of lipid mediators and cell signalling.
[14] N. Bazan,et al. Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. , 1995, Journal of neurotrauma.
[15] Kunio Kato,et al. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation , 1994, Nature.
[16] C. Zorumski,et al. The activation of phospholipase A2 and release of arachidonic acid and other lipid mediators at the synapse: the role of platelet-activating factor. , 1993, Journal of lipid mediators.
[17] C. Zorumski,et al. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor , 1992, Neuron.
[18] S H Snyder,et al. Nitric oxide: first in a new class of neurotransmitters. , 1992, Science.
[19] P. Braquet,et al. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. , 1990, The Journal of biological chemistry.
[20] 野上 予人. Involvement of platelet-activating factor (PAF) in glutamate neurotoxicity in rat neuronal cultures , 1998 .
[21] T. Yue,et al. Platelet-activating factor: a putative neuromodulator and mediator in the pathophysiology of brain injury. , 1994, Critical reviews in neurobiology.
[22] N. Bazan,et al. Platelet‐activating factor is a messenger in the electroconvulsive shock‐induced transcriptional activation of c‐fos and zif‐268 in hippocampus , 1994, Journal of neuroscience research.
[23] Yue Tl,et al. Platelet-activating factor: a putative neuromodulator and mediator in the pathophysiology of brain injury. , 1994 .
[24] D. Hosford,et al. Is there a case for PAF antagonists in the treatment of ischemic states? , 1989, Trends in pharmacological sciences.